Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Clinical trial NCT01424501 · TERMINATED
Trial details
- NCT number
- NCT01424501
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-14
- Primary completion
- 2014-04-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.